Ruth Kaufmann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ruth Kaufmann has a total of 102 co-authors. Here are the top co-authors by number of shared publications:
- Johan F. Lange
Erasmus University Medical Center
5 shared publications Johannes Jeekel
Department of Neuroscience & Anatomy, Erasmus University Medical Center, Rotterdam, the Netherlands
5 shared publications- Johannes Jeekel
Department of Neuroscience, Erasmus MC University Medical Centre, Rotterdam, The Netherlands
3 shared publications A. Montgomery
Department of Surgery, Lund University, Skåne University Hospital, Malmö, Sweden
2 shared publicationsAn P. Jairam
Department of Surgery, Catharina Ziekenhuis, Eindhoven, The Netherlands
2 shared publicationsB. East
Third Department of Surgery at Motol University Hospital, First and Second Faculty of Medicine at Charles University, Prague, Czech Republic
2 shared publications
Latest Publications
- Open Access
- 11 June 2026
- Published by Springer Nature in CVIR Endovascular
- Vol. 9 (1)
Emergency carotid artery stenting during endovascular treatment of tandem lesions in acute ischemic stroke: a single-center retrospective study
Background: Acute ischemic stroke (AIS) can be caused by multiple factors, including intracranial large vessel occlusion (LVO), severe stenosis or occlusion of the cervical carotid artery, or both (tandem lesion). The optimal treatment strategy for tandem lesions remains unclear. This single-arm retrospective study aims to measure outcomes for tandem lesion patients who were treated with emergency carotid artery stenting (eCAS) during endovascular treatment (EVT). Materials and methods: Patients who underwent EVT including eCAS for AIS with tandem lesions during the period 2015–2023 at our community teaching hospital in Western Europe were analyzed. Primary outcome was modified Rankin Scale (mRS) at 90-day follow up. Secondary outcomes were mortality within 30 days after stroke, symptomatic intracranial bleeding within 30 days after the stroke, major complications, and angiographic scores. Results: Of the 600 patients who were treated with EVT, 64 underwent 65 eCAS procedures. Preprocedural National Institutes of Health Stroke Scale (NIHSS) scores of these 64 patients ranged from 2 to 24 (median 13). Expanded treatment in cerebral infarction (eTICI) scores immediately postprocedural were 0 ( n = 1, 1.5%), 2a ( n = 6, 9.2%), 2b ( n = 31, 47.7%), 2c ( n = 6, 9.2%), or 3 ( n = 20, 30.8%). In 10.8% ( n = 7) of eCAS procedures, complications occurred during the procedure and in 18.5% ( n = 12) complications occurred during the follow-up period. In 9.2% ( n = 6) of procedures, patients experienced symptomatic intracranial bleeding. Intracranial bleeding was observed more frequently in patients with preprocedural internal carotid artery (ICA) occlusion than stenosis but the difference was not statistically significant. At 90 days follow-up, in 41.5% ( n = 27) of eCAS procedures, patients had an mRS score of ≤ 2. Binary logistic regression analysis revealed age and IV thrombolysis as significant predictors for death and age and a pretreatment low NIHSS score for a good functional outcome after 90 days (mRS 0–2). For bleeding complications none of the predictors reached statistical significance. Conclusions: Emergency carotid artery stenting during EVT for tandem lesions appears feasible with acceptable functional outcomes, despite the occurrence of symptomatic intracranial bleeding in 9% of patients. We must however await the results of randomized controlled trials before firm conclusions about the safety of eCAS can be drawn.
- 11 June 2026
- Published by Springer Nature in CVIR Endovascular
- Vol. 9 (1)
Open AccessEmergency carotid artery stenting during endovascular treatment of tandem lesions in acute ischemic stroke: a single-center retrospective study
Background: Acute ischemic stroke (AIS) can be caused by multiple factors, including intracranial large vessel occlusion (LVO), severe stenosis or occlusion of the cervical carotid artery, or both (tandem lesion). The optimal treatment strategy for tandem lesions remains unclear. This single-arm retrospective study aims to measure outcomes for tandem lesion patients who were treated with emergency carotid artery stenting (eCAS) during endovascular treatment (EVT). Materials and methods: Patients who underwent EVT including eCAS for AIS with tandem lesions during the period 2015–2023 at our community teaching hospital in Western Europe were analyzed. Primary outcome was modified Rankin Scale (mRS) at 90-day follow up. Secondary outcomes were mortality within 30 days after stroke, symptomatic intracranial bleeding within 30 days after the stroke, major complications, and angiographic scores. Results: Of the 600 patients who were treated with EVT, 64 underwent 65 eCAS procedures. Preprocedural National Institutes of Health Stroke Scale (NIHSS) scores of these 64 patients ranged from 2 to 24 (median 13). Expanded treatment in cerebral infarction (eTICI) scores immediately postprocedural were 0 ( n = 1, 1.5%), 2a ( n = 6, 9.2%), 2b ( n = 31, 47.7%), 2c ( n = 6, 9.2%), or 3 ( n = 20, 30.8%). In 10.8% ( n = 7) of eCAS procedures, complications occurred during the procedure and in 18.5% ( n = 12) complications occurred during the follow-up period. In 9.2% ( n = 6) of procedures, patients experienced symptomatic intracranial bleeding. Intracranial bleeding was observed more frequently in patients with preprocedural internal carotid artery (ICA) occlusion than stenosis but the difference was not statistically significant. At 90 days follow-up, in 41.5% ( n = 27) of eCAS procedures, patients had an mRS score of ≤ 2. Binary logistic regression analysis revealed age and IV thrombolysis as significant predictors for death and age and a pretreatment low NIHSS score for a good functional outcome after 90 days (mRS 0–2). For bleeding complications none of the predictors reached statistical significance. Conclusions: Emergency carotid artery stenting during EVT for tandem lesions appears feasible with acceptable functional outcomes, despite the occurrence of symptomatic intracranial bleeding in 9% of patients. We must however await the results of randomized controlled trials before firm conclusions about the safety of eCAS can be drawn.
- Open Access
- 30 April 2020
- Published by Springer Nature in Hernia
- Vol. 24 (4) , 913-914
A plea for unification of surgical guidelines in the COVID-19 outbreak
- 30 April 2020
- Published by Springer Nature in Hernia
- Vol. 24 (4) , 913-914
Open AccessA plea for unification of surgical guidelines in the COVID-19 outbreak
- 22 April 2020
- Published by Springer Nature in Hernia
- Vol. 25 (3) , 821-822
Comparing apples and oranges will not guide treatment the right way in umbilical hernia repair: use either level-1 evidence or guidelines
- 22 April 2020
- Published by Springer Nature in Hernia
- Vol. 25 (3) , 821-822
Comparing apples and oranges will not guide treatment the right way in umbilical hernia repair: use either level-1 evidence or guidelines
- Open Access
- 22 April 2020
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 405 (3) , 345-352
Non-cross-linked biological mesh in complex abdominal wall hernia: a cohort study
Purpose: Complex abdominal wall hernia repair (CAWHR) is a challenging procedure. Mesh prosthesis is indicated, but the use of synthetic mesh in a contaminated area may add to overall morbidity. Biological meshes may provide a solution, but little is known about long-term results. The aim of our study was to evaluate clinical efficacy and patient satisfaction following Strattice™ (PADM) placement. Methods: In this cohort study, all patients operated for CAWHR with PADM in three large community hospitals in Germany were included. Patients underwent abdominal examination, an ultrasound was performed, and patients completed quality-of-life questionnaires. The study was registered in ClinicalTrials.gov under Identifier NCT02168231. Results: Twenty-seven patients were assessed (14 male, age 67.5 years, follow-up 42.4 months). The most frequent postoperative complication was wound infection (39.1%). In no case, the PADM had to be removed. Four patients had passed away. During outpatient clinic visit, six out of 23 patients (26.1%) had a recurrence of hernia, one patient had undergone reoperation. Five patients (21.7%) had bulging of the abdominal wall. Quality-of-life questionnaires revealed that patients judged their scar with a median 3.5 out of 10 points (0 = best) and judged their restrictions during daily activities with a median of 0 out of 10.0 (0 = no restriction). Conclusions: Despite a high rate of wound infection, no biological mesh had to be removed. In some cases, therefore, the biological meshes provided a safe way out of desperate clinical situations. Both the recurrence rate and the amount of bulging are high (failure rate 47.8%). The reported quality of life is good after repair of these complex hernias.
- 22 April 2020
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 405 (3) , 345-352
Open AccessNon-cross-linked biological mesh in complex abdominal wall hernia: a cohort study
Purpose: Complex abdominal wall hernia repair (CAWHR) is a challenging procedure. Mesh prosthesis is indicated, but the use of synthetic mesh in a contaminated area may add to overall morbidity. Biological meshes may provide a solution, but little is known about long-term results. The aim of our study was to evaluate clinical efficacy and patient satisfaction following Strattice™ (PADM) placement. Methods: In this cohort study, all patients operated for CAWHR with PADM in three large community hospitals in Germany were included. Patients underwent abdominal examination, an ultrasound was performed, and patients completed quality-of-life questionnaires. The study was registered in ClinicalTrials.gov under Identifier NCT02168231. Results: Twenty-seven patients were assessed (14 male, age 67.5 years, follow-up 42.4 months). The most frequent postoperative complication was wound infection (39.1%). In no case, the PADM had to be removed. Four patients had passed away. During outpatient clinic visit, six out of 23 patients (26.1%) had a recurrence of hernia, one patient had undergone reoperation. Five patients (21.7%) had bulging of the abdominal wall. Quality-of-life questionnaires revealed that patients judged their scar with a median 3.5 out of 10 points (0 = best) and judged their restrictions during daily activities with a median of 0 out of 10.0 (0 = no restriction). Conclusions: Despite a high rate of wound infection, no biological mesh had to be removed. In some cases, therefore, the biological meshes provided a safe way out of desperate clinical situations. Both the recurrence rate and the amount of bulging are high (failure rate 47.8%). The reported quality of life is good after repair of these complex hernias.
- 6 April 2020
- Published by Springer Nature in Hernia
- Vol. 25 (1) , 247-248
The power of level-1 evidence in umbilical hernia repair: mesh repair is supported by strong evidence
- 6 April 2020
- Published by Springer Nature in Hernia
- Vol. 25 (1) , 247-248
The power of level-1 evidence in umbilical hernia repair: mesh repair is supported by strong evidence
- 1 February 2020
- Published by Elsevier in Journal of Surgical Research
- Vol. 246, 560-567
Zinc-Impregnated Mesh for Abdominal Wall Repair Reduces Infection in a Rat Model of Peritonitis
- 1 February 2020
- Published by Elsevier in Journal of Surgical Research
- Vol. 246, 560-567
Zinc-Impregnated Mesh for Abdominal Wall Repair Reduces Infection in a Rat Model of Peritonitis
- Top Cited PapersOpen Access
- 9 January 2020
- Published by Oxford University Press (OUP) in BJS Open
- Vol. 4 (2) , 342-353
EHS and AHS guidelines for treatment of primary ventral hernias in rare locations or special circumstances
Background: Rare locations of hernias, as well as primary ventral hernias under certain circumstances (cirrhosis, dialysis, rectus diastasis, subsequent pregnancy), might be technically challenging. The aim was to identify situations where the treatment strategy might deviate from routine management. Methods: The guideline group consisted of surgeons from the European and Americas Hernia Societies. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach was used in formulating the recommendations. The Scottish Intercollegiate Guidelines Network (SIGN) critical appraisal checklists were used to evaluate the quality of full-text papers. A systematic literature search was performed on 1 May 2018 and updated 1 February 2019. The Appraisal of Guidelines for Research and Evaluation (AGREE) instrument was followed. Results: Literature was limited in quantity and quality. A majority of the recommendations were graded as weak, based on low quality of evidence. In patients with cirrhosis or on dialysis, a preperitoneal mesh repair is suggested. Subsequent pregnancy is a risk factor for recurrence. Repair should be postponed until after the last pregnancy. For patients with a concomitant rectus diastasis or those with a Spigelian or lumbar hernia, no recommendation could be made for treatment strategy owing to lack of evidence. Conclusion: This is the first European and American guideline on the treatment of umbilical and epigastric hernias in patients with special conditions, including Spigelian and lumbar hernias. All recommendations were weak owing to a lack of evidence. Further studies are needed on patients with rectus diastasis, Spigelian and lumbar hernias.
- 9 January 2020
- Published by Oxford University Press (OUP) in BJS Open
- Vol. 4 (2) , 342-353
Top Cited PapersOpen AccessEHS and AHS guidelines for treatment of primary ventral hernias in rare locations or special circumstances
Background: Rare locations of hernias, as well as primary ventral hernias under certain circumstances (cirrhosis, dialysis, rectus diastasis, subsequent pregnancy), might be technically challenging. The aim was to identify situations where the treatment strategy might deviate from routine management. Methods: The guideline group consisted of surgeons from the European and Americas Hernia Societies. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach was used in formulating the recommendations. The Scottish Intercollegiate Guidelines Network (SIGN) critical appraisal checklists were used to evaluate the quality of full-text papers. A systematic literature search was performed on 1 May 2018 and updated 1 February 2019. The Appraisal of Guidelines for Research and Evaluation (AGREE) instrument was followed. Results: Literature was limited in quantity and quality. A majority of the recommendations were graded as weak, based on low quality of evidence. In patients with cirrhosis or on dialysis, a preperitoneal mesh repair is suggested. Subsequent pregnancy is a risk factor for recurrence. Repair should be postponed until after the last pregnancy. For patients with a concomitant rectus diastasis or those with a Spigelian or lumbar hernia, no recommendation could be made for treatment strategy owing to lack of evidence. Conclusion: This is the first European and American guideline on the treatment of umbilical and epigastric hernias in patients with special conditions, including Spigelian and lumbar hernias. All recommendations were weak owing to a lack of evidence. Further studies are needed on patients with rectus diastasis, Spigelian and lumbar hernias.
- Top Cited PapersOpen Access
- 9 January 2020
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 107 (3) , 171-190
Guidelines for treatment of umbilical and epigastric hernias from the European Hernia Society and Americas Hernia Society
Background: Umbilical and epigastric hernia repairs are frequently performed surgical procedures with an expected low complication rate. Nevertheless, the optimal method of repair with best short- and long-term outcomes remains debatable. The aim was to develop guidelines for the treatment of umbilical and epigastric hernias. Methods: The guideline group consisted of surgeons from Europe and North America including members from the European Hernia Society and the Americas Hernia Society. The Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach, the Scottish Intercollegiate Guidelines Network (SIGN) critical appraisal checklists, and the Appraisal of Guidelines for Research and Evaluation (AGREE) instrument were used. A systematic literature search was done on 1 May 2018, and updated on 1 February 2019. Results: Literature reporting specifically on umbilical and epigastric hernias was limited in quantity and quality, resulting in a majority of the recommendations being graded as weak, based on low-quality evidence. The main recommendation was to use mesh for repair of umbilical and epigastric hernias to reduce the recurrence rate. Most umbilical and epigastric hernias may be repaired by an open approach with a preperitoneal flat mesh. A laparoscopic approach may be considered if the hernia defect is large, or if the patient has an increased risk of wound morbidity. Conclusion: This is the first European and American guideline on the treatment of umbilical and epigastric hernias. It is recommended that symptomatic umbilical and epigastric hernias are repaired by an open approach with a preperitoneal flat mesh.
- 9 January 2020
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 107 (3) , 171-190
Top Cited PapersOpen AccessGuidelines for treatment of umbilical and epigastric hernias from the European Hernia Society and Americas Hernia Society
Background: Umbilical and epigastric hernia repairs are frequently performed surgical procedures with an expected low complication rate. Nevertheless, the optimal method of repair with best short- and long-term outcomes remains debatable. The aim was to develop guidelines for the treatment of umbilical and epigastric hernias. Methods: The guideline group consisted of surgeons from Europe and North America including members from the European Hernia Society and the Americas Hernia Society. The Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach, the Scottish Intercollegiate Guidelines Network (SIGN) critical appraisal checklists, and the Appraisal of Guidelines for Research and Evaluation (AGREE) instrument were used. A systematic literature search was done on 1 May 2018, and updated on 1 February 2019. Results: Literature reporting specifically on umbilical and epigastric hernias was limited in quantity and quality, resulting in a majority of the recommendations being graded as weak, based on low-quality evidence. The main recommendation was to use mesh for repair of umbilical and epigastric hernias to reduce the recurrence rate. Most umbilical and epigastric hernias may be repaired by an open approach with a preperitoneal flat mesh. A laparoscopic approach may be considered if the hernia defect is large, or if the patient has an increased risk of wound morbidity. Conclusion: This is the first European and American guideline on the treatment of umbilical and epigastric hernias. It is recommended that symptomatic umbilical and epigastric hernias are repaired by an open approach with a preperitoneal flat mesh.
- Open Access
- 17 August 2019
- Published by Springer Nature in Hernia
- Vol. 23 (5) , 847-857
A systematic review on surgical treatment of primary epigastric hernias
Objective In this systematic review, we evaluated all literature reporting on the surgical treatment of primary epigastric hernias, primarily focusing on studies comparing laparoscopic and open repair, and mesh reinforcement and suture repair. Methods A literature search was conducted in Embase.com, PubMed and the Cochrane Library up to 24 April 2019. This review explicitly excluded literature on incisional hernias, ventral hernias not otherwise specified, and isolated (para)umbilical hernias. Primary outcome measures of interest were early and late postoperative complications. Results We obtained a total of 8516 articles and after a strict selection only seven retrospective studies and one randomised controlled trial (RCT) on treatment of primary epigastric hernia were included. In one study (RCT) laparoscopic repair led to less postoperative pain (VAS) compared to open repair (3.6 versus 2.4, p < 0.001). No significant differences in early postoperative complications and recurrences were observed. Mesh reinforcement was associated with lower recurrence rates than suture repair in two studies (2.2% versus 5.6%, p = 0.001 and 3.1% versus 14.7%, p = 0.0475). This result was not sustained in all studies. No differences were observed in early postoperative complications after mesh or suture repair. Conclusions This review demonstrated that studies investigating surgical treatment of primary epigastric hernias are scarce. The best available evidence suggests that mesh reinforcement in primary epigastric hernia repair possibily leads to less recurrences and that laparoscopic repair leads to less postoperative pain. Due to the high risk of selection bias of included studies and heterogenic study populations, no clear recommendations can be conducted. High-quality studies with well-defined patient groups and clear endpoints, primarily focusing on primary epigastric hernias, are mandatory.
- 17 August 2019
- Published by Springer Nature in Hernia
- Vol. 23 (5) , 847-857
Open AccessA systematic review on surgical treatment of primary epigastric hernias
Objective In this systematic review, we evaluated all literature reporting on the surgical treatment of primary epigastric hernias, primarily focusing on studies comparing laparoscopic and open repair, and mesh reinforcement and suture repair. Methods A literature search was conducted in Embase.com, PubMed and the Cochrane Library up to 24 April 2019. This review explicitly excluded literature on incisional hernias, ventral hernias not otherwise specified, and isolated (para)umbilical hernias. Primary outcome measures of interest were early and late postoperative complications. Results We obtained a total of 8516 articles and after a strict selection only seven retrospective studies and one randomised controlled trial (RCT) on treatment of primary epigastric hernia were included. In one study (RCT) laparoscopic repair led to less postoperative pain (VAS) compared to open repair (3.6 versus 2.4, p < 0.001). No significant differences in early postoperative complications and recurrences were observed. Mesh reinforcement was associated with lower recurrence rates than suture repair in two studies (2.2% versus 5.6%, p = 0.001 and 3.1% versus 14.7%, p = 0.0475). This result was not sustained in all studies. No differences were observed in early postoperative complications after mesh or suture repair. Conclusions This review demonstrated that studies investigating surgical treatment of primary epigastric hernias are scarce. The best available evidence suggests that mesh reinforcement in primary epigastric hernia repair possibily leads to less recurrences and that laparoscopic repair leads to less postoperative pain. Due to the high risk of selection bias of included studies and heterogenic study populations, no clear recommendations can be conducted. High-quality studies with well-defined patient groups and clear endpoints, primarily focusing on primary epigastric hernias, are mandatory.
- 1 May 2019
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 65, 120-127
Repair of complex abdominal wall hernias with a cross-linked porcine acellular matrix: cross-sectional results of a Dutch cohort study
Background: The use of synthetic mesh in potentially contaminated and contaminated incisional hernias may lead to a higher morbidity and mortality. Biological meshes may provide a solution, but since these meshes are rarely used, little is known about long-term results. The aim of this cohort study was to evaluate the long-term clinical efficacy and patient satisfaction following Permacol (TM) in complex abdominal wall hernia repair (CAWHR) patients in a cross-sectional fashion. Materials and methods: All patients were operated for CAWHR with Permacol (TM) in the Netherlands between 2009 and 2012. The design was a multicenter cross-sectional cohort study. The STROCSS statement was followed. Patients were interviewed, underwent abdominal examination, and completed quality-of-life questionnaires. ClinicalTrials.gov Identifier NCT02166112. Research Registry Identifier researchregistry4713. Results: Seventy-seven patients were seen in the outpatient clinic. Their hernias were classified as potentially contaminated in 25 patients (32.5%) and infected in 52 patients (67.5%). The mean follow-up was 22.2 +/- 12.6 months. The most frequent postoperative complication was wound infection (n = 21; 27.3%), meshes had to be removed in five patients (6.5%). By the time of their visit to the outpatient clinic, 22 patients (28.6%) had a recurrence of whom ten (13%) had undergone reoperation. Thirty-nine patients (50.6%) had bulging of the abdominal wall. Quality-of-life questionnaires revealed that patients graded their health status with a mean 6.8 (+/- 1.8) out of 10 points. Conclusion: Bulging and recurrence are frequently observed in patients treated with Permacol (TM) for CAWHR. Considering both recurrence and bulging as undesirable outcomes of treatment, a total of 46 patients (59.7%) had an unfavorable outcome. Infection rates were high, but comparable with similar patient cohorts. Quality-of-life questionnaires revealed that patients were satisfied with their general health, but scored significantly lower on most quality-of-life modalities of the Short Form-36 questionnaire.
- 1 May 2019
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 65, 120-127
Repair of complex abdominal wall hernias with a cross-linked porcine acellular matrix: cross-sectional results of a Dutch cohort study
Background: The use of synthetic mesh in potentially contaminated and contaminated incisional hernias may lead to a higher morbidity and mortality. Biological meshes may provide a solution, but since these meshes are rarely used, little is known about long-term results. The aim of this cohort study was to evaluate the long-term clinical efficacy and patient satisfaction following Permacol (TM) in complex abdominal wall hernia repair (CAWHR) patients in a cross-sectional fashion. Materials and methods: All patients were operated for CAWHR with Permacol (TM) in the Netherlands between 2009 and 2012. The design was a multicenter cross-sectional cohort study. The STROCSS statement was followed. Patients were interviewed, underwent abdominal examination, and completed quality-of-life questionnaires. ClinicalTrials.gov Identifier NCT02166112. Research Registry Identifier researchregistry4713. Results: Seventy-seven patients were seen in the outpatient clinic. Their hernias were classified as potentially contaminated in 25 patients (32.5%) and infected in 52 patients (67.5%). The mean follow-up was 22.2 +/- 12.6 months. The most frequent postoperative complication was wound infection (n = 21; 27.3%), meshes had to be removed in five patients (6.5%). By the time of their visit to the outpatient clinic, 22 patients (28.6%) had a recurrence of whom ten (13%) had undergone reoperation. Thirty-nine patients (50.6%) had bulging of the abdominal wall. Quality-of-life questionnaires revealed that patients graded their health status with a mean 6.8 (+/- 1.8) out of 10 points. Conclusion: Bulging and recurrence are frequently observed in patients treated with Permacol (TM) for CAWHR. Considering both recurrence and bulging as undesirable outcomes of treatment, a total of 46 patients (59.7%) had an unfavorable outcome. Infection rates were high, but comparable with similar patient cohorts. Quality-of-life questionnaires revealed that patients were satisfied with their general health, but scored significantly lower on most quality-of-life modalities of the Short Form-36 questionnaire.